World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
92
Citations
25073
World Ranking
11459
National Ranking
5871

Peter C. Adamson publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Peter C. Adamson sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 427 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Peter C. Adamson D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Peter C. Adamson sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 92 D-Index — 45th percentile

45% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Peter C. Adamson is affiliated with the Children's Hospital of Philadelphia in the United States. Their research primarily spans the field of Medicine, with contributions to several subfields including Pediatrics, Perinatology and Child Health, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health, and Genetics.

The scientist's work covers various key topics such as:

  • Childhood Cancer Survivors' Quality of Life
  • Acute Lymphoblastic Leukemia research
  • Pharmaceutical studies and practices
  • Neuroblastoma Research and Treatments
  • Lymphoma Diagnosis and Treatment
  • Cancer therapeutics and mechanisms
  • Adolescent and Pediatric Healthcare

Notable recent papers by Peter C. Adamson include:

  • Rituximab for High-Risk, Mature B-Cell Non-Hodgkin's Lymphoma in Children (2020), published in New England Journal of Medicine
  • Activity of Crizotinib in Patients with ALK-Aberrant Relapsed/Refractory Neuroblastoma: A Children's Oncology Group Study (ADVL0912) (2021), published in Clinical Cancer Research
  • Phase I/II trial of vorinostat and radiation and maintenance vorinostat in children with diffuse intrinsic pontine glioma: A Children's Oncology Group report (2021), published in Neuro-Oncology
  • Survivorship Care Plans and the Commission on Cancer Standards: The Increasing Need for Better Strategies to Improve the Outcome for Survivors of Cancer (2020), published in JCO Oncology Practice
  • ACCELERATE - Five years accelerating cancer drug development for children and adolescents (2022), published in European Journal of Cancer

Frequent co-authors working with Adamson include:

  • Paul Wilpert
  • Karin de Boer
  • New York
  • James Allen
  • Edwin Curley

Peter C. Adamson has published regularly in several academic venues. The most frequent publication venues include:

  • Archiv für Geschichte der Philosophie
  • European Journal of Cancer
  • Neuro-Oncology
  • Pediatric Blood & Cancer
  • Clinical Pharmacology & Therapeutics

The body of work by Adamson focuses extensively on pediatric oncology and related areas, covering clinical trials, treatments, and survivorship care plans among vulnerable child and adolescent populations.

Best Publications

  • Understanding and Managing Methotrexate Nephrotoxicity

    Brigitte C. Widemann;Peter C. Adamson

  • Ethosuximide, Valproic Acid, and Lamotrigine in Childhood Absence Epilepsy

    Tracy A. Glauser;Tracy A. Glauser;Avital Cnaan;Shlomo Shinnar;Deborah G. Hirtz

  • Safety and activity of crizotinib for paediatric patients with refractory solid tumours or anaplastic large-cell lymphoma: a Children's Oncology Group phase 1 consortium study

    Yael P Mossé;Megan S Lim;Stephan D Voss;Keith Wilner

  • Declining childhood and adolescent cancer mortality.

    Malcolm A. Smith;Sean F. Altekruse;Peter C. Adamson;Gregory H. Reaman

  • Pharmacokinetics and Safety of Intravenous Voriconazole in Children after Single- or Multiple-Dose Administration

    Thomas J. Walsh;Mats O. Karlsson;Timothy Driscoll;Adriano G. Arguedas

  • Lymphocyte Migration Through Brain Endothelial Cell Monolayers Involves Signaling Through Endothelial ICAM-1 Via a Rho-Dependent Pathway

    Peter Adamson;Sandrine Etienne;Pierre-Olivier Couraud;Virginia Calder

  • Targeting ALK With Crizotinib in Pediatric Anaplastic Large Cell Lymphoma and Inflammatory Myofibroblastic Tumor: A Children's Oncology Group Study.

    Yael P. Mossé;Stephan D. Voss;Megan S. Lim;Delphine Rolland

  • High-Dose Methotrexate-Induced Nephrotoxicity in Patients with Osteosarcoma: Incidence, Treatment, and Outcome

    Brigitte C. Widemann;Frank M. Balis;Beate Kempf-Bielack;Stefan Bielack

  • ICAM-1-Coupled Cytoskeletal Rearrangements and Transendothelial Lymphocyte Migration Involve Intracellular Calcium Signaling in Brain Endothelial Cell Lines

    Sandrine Etienne-Manneville;Jean-Baptiste Manneville;Peter Adamson;Barry Wilbourn

  • Ethosuximide, Valproic Acid and Lamotrigine in Childhood Absence Epilepsy: Initial Monotherapy Outcomes at 12 months

    Tracy A. Glauser;Avital Cnaan;Shlomo Shinnar;Deborah G. Hirtz

  • Lovastatin inhibits brain endothelial cell Rho-mediated lymphocyte migration and attenuates experimental autoimmune encephalomyelitis

    John Greenwood;Claire E. Walters;Gareth Pryce;Naheed Kanuga

  • Pharmacokinetics, Safety, and Tolerability of Caspofungin in Children and Adolescents

    Thomas J. Walsh;Peter C. Adamson;Nita L. Seibel;Patricia M. Flynn

  • Shortening the Timeline of Pediatric Phase I Trials: The Rolling Six Design

    Jeffrey M. Skolnik;Jeffrey S. Barrett;Bhuvana Jayaraman;Dimple Patel

  • Subretinal transplantation of genetically modified human cell lines attenuates loss of visual function in dystrophic rats

    Raymond D. Lund;Peter Adamson;Yves Sauvé;David J. Keegan

  • Phase I Trial and Pharmacokinetic Study of Bevacizumab in Pediatric Patients With Refractory Solid Tumors: A Children's Oncology Group Study

    Julia L. Glade Bender;Peter C. Adamson;Joel M. Reid;Lu Xu

  • A Phase I Clinical Trial of the hu14.18-IL2 (EMD 273063) as a Treatment for Children with Refractory or Recurrent Neuroblastoma and Melanoma: a Study of the Children’s Oncology Group

    Kaci L. Osenga;Jacquelyn A. Hank;Mark R. Albertini;Jacek Gan

  • Rapid detection and identification of Candida, Aspergillus, and Fusarium species in ocular samples using nested PCR

    Emma E. M. Jaeger;Nora M. Carroll;Sarah Choudhury;Anthony A. S. Dunlop

  • Long-term preservation of cortically dependent visual function in RCS rats by transplantation

    P. J. Coffey;S. Girman;S. M. Wang;L. Hetherington

  • Chemoimmunotherapy Reinduction With Epratuzumab in Children With Acute Lymphoblastic Leukemia in Marrow Relapse: A Children's Oncology Group Pilot Study

    Elizabeth A. Raetz;Mitchell S. Cairo;Michael J. Borowitz;Susan M. Blaney

  • Phosphorylation of vascular endothelial cadherin controls lymphocyte emigration

    Patric Turowski;Roberta Martinelli;Rebecca Crawford;David Wateridge

Frequent Co-Authors

Frank M. Balis
Frank M. Balis Children's Hospital of Philadelphia
Susan M. Blaney
Susan M. Blaney Baylor College of Medicine
Mark Krailo
Mark Krailo University of Southern California
David G. Poplack
David G. Poplack Baylor College of Medicine
John M. Maris
John M. Maris Children's Hospital of Philadelphia
Malcolm A. Smith
Malcolm A. Smith National Institutes of Health
Todd A. Alonzo
Todd A. Alonzo University of Southern California
Elizabeth A. Raetz
Elizabeth A. Raetz New York University
Yael P. Mosse
Yael P. Mosse Children's Hospital of Philadelphia
John Greenwood
John Greenwood University College London

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

The medical field offers a wide range of online degrees and certifications that can lead to rewarding careers. For those interested in pharmaceuticals, pursuing one of the many online pharmacy programs can provide a flexible path to becoming a licensed pharmacist. These programs often combine remote coursework with in-person clinical experiences.

Another in-demand area is health informatics. Earning a health information management bachelor degree online prepares students for roles managing patient data and health records, which are crucial for modern healthcare systems.

Those looking to quickly enter the workforce may consider a medical billing and coding certification online. These certifications provide practical skills that are highly valued by hospitals and clinics.

Nursing is another prominent career path with flexible study options. The cheapest np school options make it possible to qualify for advanced practice roles without heavy student debt.

Exploring these diverse online degrees can open new career opportunities in America’s healthcare sector, whether in clinical, administrative, or specialty roles.

Best Scientists Citing Peter C. Adamson

Trending Scientists

Recently Published Articles